Glenmark Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic Fluphenazine Hydrochloride tablets used to treat certain types of mental disorders. The approval granted by the US Food & Drug Administration (US FDA) is for Fluphenazine Hydrochloride tablets of strengths 1 mg, 2.5 mg, 5 mg and 10 mg, Glenmark said in a statement.
These are the generic versions of Prolixin tablets in same strengths of Apothecon Inc, it added. The company's Fluphenazine Hydrochloride tablets will be distributed in the US by Glenmark Pharmaceuticals Inc, USA, it said.
For the 12 months ended September 2023, Prolixin tablets in the same strengths achieved annual sales of approximately USD 18.1 million, Glenmark said citing IQVIA data.
Also read: Glenmark Pharma shares gain on becoming first to launch Triple-drug FDC for Type 2 Diabetes
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
AAP protest today: Delhi traffic police issues traffic advisory, security at BJP headquarters beefed up
May 19, 2024 11:26 AM
BJP is planning to ban RSS, says Shiv Sena (UBT) chief Uddhav Thackeray
May 18, 2024 8:01 PM
Punjab Lok Sabha elections: Complete list of Congress candidates
May 18, 2024 4:08 PM
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM